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Table 1
Prevalence of Buruli ulcer in the Territory of Songololo, July-August 2008
Health Zone Population Number
BU case
Total
Number
Active BU
Number
Inactive
UB
Global
preva-
lence/105
Active BU
preva-
lence/105
Inactive
BU
prevalence/105
Kimpese 146,108 376 141 235 257.3 96.5 160.8
Nsona-Mpangu 91,310 399 118 281 437.0 129.2 307.7290 15th ICID Abstracts / International Journa
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revalence anddistribution of Buruli ulcer in the Songololo Ter-
itory, Democratic Republic of Congo
. Phanzu Mavinga1,∗, P. Suykerbuyk2, P. Lukanu Ngwala3, J.-
. Minuku Masamba4, P. Saunderson5, P. Lutumba Tshindele6, F.
ortaels7, M. Boelaert2
Institut Médical Evangélique (IME) of Kimpese, Kimpese, Bas-Congo,
ongo, Democratic Republic of
Institute of Tropical Medicine, Antwerp, Belgium
Health Zone of Kimpese, Kimpese, Bas-Congo, Congo, Democratic
epublic of
Health Zone of Nsona Mpangu, Nsona Mpangu, Bas-Congo, Congo,
emocratic Republic of
American Leprosy Missions, Greenville, SC, USA
InstitutNational de Recherche Biomeıˇ dicale, Kinshasa, Congo,Demo-
ratic Republic of
Institute of Tropical Medicine, Antwerp, BelgiumTotal 237,418 775 259 516 326.4 109.1 217.3
Background: Cutaneous infection by Mycobacterium ulcerans,
also known as Buruli ulcer (BU), represents the thirdmost common
mycobacterial disease in the world after tuberculosis and leprosy.
The General Reference Hospital (GRH) of the “Institut Médical
Evangélique” (IME) of Kimpese, located in Songololo, launched a
BU control project in 2004. Although a recent study have shown a
strong increase in the number of admitted BU cases after the start
of the Project, data on the exact prevalence and burden of disease in
the Territorywas lacking. This study aimed to assess the prevalence
and the distribution of BU, and to determine the project coverage
in the Songololo Territory.
Methods: We conducted a two-month (July-August 2008)
cross-sectional survey using the door to door method simultane-
ously in the two rural health zones (RHZ) of the Songololo Territory
(RHZ of Kimpese and Nsona-Mpangu), containing each twenty
health areas. Cases were deﬁned clinically as active (evolutive) BU
and inactive (healed) BU in accordancewithWHO-case deﬁnitions.
Results: Out of a total population of 237,418 inhabitants, 775
BU patients were detected with 259 active and 516 inactive cases
(Table 1). The overall prevalence of BU in Songololo Territory
was 326.4/100,000 inhabitants, varying from 0 to 2751.5/100,000
inhabitants between health areas. The geographical distribution is
presented in Figure 1. Of the 259 patients with active BU detected,
25 were admitted in the GRH IME/Kimpese from January to August
2008. Thus, the project coverage was 10% only.
Distribution of Buruli ulcer in the Songololo Territory, July-
August 2008.
Conclusion: Our study highlights the need of considering new
control strategieswhich areboth socially andﬁnancially acceptable
and appropriate for the concerned communities. Decentralization
and integration of BU control activitiesmay improve access to diag-
nosis and care at the most peripheral level of the health system. A
close collaboration between the BU control project and the health
zones is essential for the implementation of a simple, functional,
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inmate patients with lower respiratory symptoms of any duration
conﬁned in those places and perform mycobacterial culture.
http://dx.doi.org/10.1016/j.ijid.2012.05.96615th ICID Abstracts / International Journa
nd efﬁcient active surveillance system in a resource limited con-
ext.
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rug resistant tuberculosis in urban Thai children: a 10 year
eview
. Punpanich1,∗, R. Rattanasataporn2, V. Treeratweeraphong2
Queen Sirikit National Institute of Child Health, College of Medicine,
angsit University, Bangkok, Thailand
Queen Sirikit National Institute of Child Health, Bangkok, Thailand
Background: Problem of drug resistant tuberculosis (DR-TB)
as currently gained a major concern in magnitude. In the settings
here the rates of DR-TB may be high, initial treatment regimen
ay be modiﬁed by knowledge of the resistance patterns. We
imed to determine the prevalence, susceptibility pattern, and risk
actors of drug resistant tuberculosis in pediatric patients.
Methods: Retrospective descriptive study was conducted in
hildren (0-18 years) receiving care at Queen Sirikit National
nstitute of Child Health who had positive culture and available
usceptibility pattern ofM. tuberculosis. Drug resistant tuberculosis
DR-TB)was deﬁned as resistance to at least one of antituberculosis
rugs.
Results: Susceptibility resultswere available in 78 cases (85.7%)
ut of 91 positive cultures for M. tuberculosis. The sensitivity of
uberculin test using the cut-off point of 10mm. induration for
on-HIV infected patient, and 5mm. induration for HIV infected
atients were 71.4% and 14.3% respectively. Resistance to at least
ne anti-tuberculosis drugwere found in 22 cases (28.2%) forwhich
treptomycin resistance being the most common (21.7%) followed
y isoniazid (11.5%) and rifampicin (5.1%). Multi-drug resistance
MDR), i.e. resistance to at least both isoniazid and rifampicin, was
bserved in 3 cases (3.8%) of cases. A history of previous treatment
nd bone and joint involvement were signiﬁcantly higher for DR-
B cases: 18.2% vs. 1.8%, p =0.0078 and 22.7 vs. 1.8%, p =0.0018, for
R-TB and drug susceptible-tuberculosis, respectively. Cases with
R-TB were signiﬁcantly less likely to complete their treatment
ourse compared to their counterpart (54.5% vs. 87.5%, p =0.0018).
o signiﬁcant differences in resistance rate by age, gender, clinical
resentations,HIV serostatuswasobserved.Case fatality rateswere
.7% and 4.5% for drug susceptible and drug resistant tuberculosis.
Conclusion: The sensitivity of tuberculin skin test in detecting
ulture-proven tuberculosis test was rather low among both HIV
nfected and non-HIV infected children. The rates of isoniazid and
treptomycin resistance are causes of concern. History of previ-
us treatment, involvement of bone and joint were associated with
rug resistant tuberculosis. Ethambutol may be preferable com-
ared to streptomycin in an empirical treatment regimen due to
he high rate of streptomycin resistance.
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Tuberculosis in prisoners in four reclusion centers in Medellin
and Bucaramanga, Colombia. 2010-2011
Z. Rueda1,∗, L. López2, L.A. Vélez1, D.M. Marín1, M.R. Giraldo3, H.
Pulido4, L.C. Orozco5, F. Montes6, D. Villa-Villa7, M.P. Arbeláez1
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Background: Jails are considered reservoirs of Tb, therefore, an
important threat to public health. Objective: to determine the inci-
dence and epidemiology of Tb in prisoners in four jails, two of each
for male and female inmates.
Methods: Prospective cohort study. All prisoners with respira-
tory symptoms and their personal contacts were evaluated. After
signed consent forms, we collected three spontaneous sputum and
bloodsamplesonconsecutivedays.Auramine-rodhamine stainand
cultures in thin layer agar, Löwestein-Jensen and MGIT were per-
formed. Additionally, susceptibility tests were performed for ﬁrst
line drugs and HIV testing. We also collected socio-demographic
and clinical data, and personal and family history. To determine
overcrowding conditions, the width and length of the cells were
measured and number of prisoners in each cell was determined.
Results: We evaluated 2103 prisoners, and identiﬁed 961 with
lower respiratory symptoms (92.5% were men). Among them, 47
were diagnosed with Tb, 12 (25.5%) were detected only by culture.
The annual incidence was 494 cases/100000 prisoners (Medellin:
515/100000; Bucaramanga: 443/100000). The median age was 30
years, 25.5% (12) had less than 15 days of cough, 12.7% had past
history of TB and 44.6% (21) had prior contact with a Tb patient, 13
of the contacts were prisoners. TB-HIV co-infection was diagnosed
in two cases, andwe found two cases resistant to streptomycin and
one to isoniazid. The median of square meters per person was 1.84
(IQR=0.96-3.56).
Conclusion: TB in jails was very high in our study, about 20
times higher than in general population in Colombia that is 25
cases/100000 inhabitants. This illness should be considered in
